Boehringer Ingelheim (Canada) Ltd.
France Lépine v Boehringer Ingelheim (Canada) Ltd.
Superior Court, district of Montréal, no 500-06-000463-097
On December 19, 2011, the Québec Superior Court authorized the institution of a class action filed by France Lépine against Boehringer Ingelheim (Canada) Ltd. and approved the settlement agreement reached in the class action. The following class was authorized for settlement purposes only:
All persons resident in Québec who were prescribed and ingested Mirapex at any time up to July 13, 2011 and all persons who were resident in Québec at a time they were prescribed and ingested Mirapex.
The final amount of each member’s indemnity has been calculated and communicated to them. Therefore, the administration of the class action is now complete.
The deadline to opt-out of the settlement was March 2, 2012.
The deadline for submitting a claim was February 17, 2012.
Lauzon Bélanger Lespérance inc.
286 Saint-Paul Street West, suite100
Montréal (Québec) H2Y 2A3
Counsel for Defendants
McMillan S.E.N.C.R.L., s.r.l.
1000 Sherbrooke Street West, suite 2700
Montréal (Québec) H3A 3G4
Amendment to the Settlement Agreement
Judgment approving the Amendment to the Settlement Agreement (French version only)
Notice of Approval of Settlement Agreement
Notice of Settlement Approval Hearing